Xtl Biopharmaceuticals (XTLB) Income from Non-Controlling Interests (2012 - 2024)
Xtl Biopharmaceuticals (XTLB) posted quarterly Income from Non-Controlling Interests of $991000.0 for Q3 2024, up 135.63% year-on-year from $420566.3 in Q4 2023, and up 135.63% on a QoQ basis from -$2.8 million in Q3 2023.
Xtl Biopharmaceuticals (XTLB) Income from Non-Controlling Interests (2012 - 2024) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Income from Non-Controlling Interests for 8 consecutive years, with $991000.0 the latest figure, recorded in Q3 2024.
- Quarterly Income from Non-Controlling Interests rose 135.63% year-over-year to $991000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$2.5 million (up 28.83% YoY) and the FY2020 annual result came in at -$3.0 million, down 119.3% from the prior year.
- Income from Non-Controlling Interests rose to $991000.0 in Q3 2024 per XTLB's latest filing, from -$2.8 million in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for XTLB reached as high as $991000.0 in Q3 2024 and fell as low as -$2.8 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 991,000.00 |
| Sep 30, 2023 | -2.78 Mn |
| Dec 31, 2017 | -878,000.00 |
| Sep 30, 2017 | 135,000.00 |
| Jun 30, 2017 | -35,000.00 |
| Mar 31, 2017 | -3,000.00 |
| Dec 31, 2016 | -1.32 Mn |
| Sep 30, 2016 | -286,000.00 |
| Jun 30, 2016 | -477,000.00 |
| Mar 31, 2016 | 27,000.00 |
| Dec 31, 2015 | -2.37 Mn |
| Sep 30, 2015 | -443,000.00 |
| Jun 30, 2015 | -427,000.00 |
| Mar 31, 2015 | -1.08 Mn |
| Dec 31, 2014 | -768,000.00 |
| Sep 30, 2014 | -510,000.00 |
| Jun 30, 2014 | -563,000.00 |
| Mar 31, 2014 | 686,000.00 |
| Dec 31, 2013 | -1.15 Mn |
| Sep 30, 2013 | 549,000.00 |